Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity - Schedule of Share-based Compensation, Stock Options, Activity (Details)

v3.21.1
Stockholders' Equity - Schedule of Share-based Compensation, Stock Options, Activity (Details) - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Equity [Abstract]    
Shares, Balance, January 1, 2020 80,000 290,000
Shares, Granted
Shares, Forfeited (210,000)
Shares, Balance, December 31, 2020 80,000 80,000
Shares, Exercisable, Balance, December 31, 2020 80,000 53,333
Weighted Average Exercise Price, Balance, January 1, 2020 $ 7.01 $ 5.55
Weighted Average Exercise Price, Granted
Weighted Average Exercise Price, Forfeited 5.00
Weighted Average Exercise Price, Balance, December 31, 2020 7.01 7.01
Weighted Average Exercise Price, Exercisable, Balance, December 31, 2020 $ 7.01 $ 7.01
Remaining Contractual Life in Years, Balance, January 1, 2020 2 years 8 months 12 days 4 years 2 months 12 days
Remaining Contractual Life in Years, Granted 0 years 0 years
Remaining Contractual Life in Years, Forfeited 0 years 0 years
Remaining Contractual Life in Years, Balance, December 31, 2020 2 years 8 months 12 days 2 years 8 months 12 days
Remaining Contractual Life in Years, Exercisable, Balance, December 31, 2020 2 years 8 months 12 days 3 years 8 months 12 days
Aggregate Intrinsic Value, Balance, January 1, 2020
Aggregate Intrinsic Value, Granted
Aggregate Intrinsic Value, Forfeited
Aggregate Intrinsic Value, Balance, December 31, 2020
Aggregate Intrinsic Value, Exercisable, Balance, December 31, 2020